1. Jia, Yongqin, Li, Haiyu, Liu, Geli, Song, Fangzhou. 2018. SMAGP a novel biomarker of cervical cancer development and progression. In OncoTargets and therapy, 11, 6925-6935. doi:10.2147/OTT.S175808. https://pubmed.ncbi.nlm.nih.gov/30410350/
2. Ni, Hongzao, Ji, Daofei, Huang, Zhixiong, Li, Jing. 2020. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway. In Archives of biochemistry and biophysics, 695, 108628. doi:10.1016/j.abb.2020.108628. https://pubmed.ncbi.nlm.nih.gov/33049294/
3. Han, Guoqing, Wang, Xingdong, Pu, Ke, Li, Qingguo, Tong, Xiaoguang. 2024. Identification of a prognosis-related phagocytosis regulator gene signature in medulloblastoma. In Heliyon, 10, e34474. doi:10.1016/j.heliyon.2024.e34474. https://pubmed.ncbi.nlm.nih.gov/39130452/
4. Tarbé, Nesrine G, Rio, Marie-Christine, Hummel, Susanne, Weidle, Ulrich H, Zöller, Margot. . Overexpression of the small transmembrane and glycosylated protein SMAGP supports metastasis formation of a rat pancreatic adenocarcinoma line. In International journal of cancer, 117, 913-22. doi:. https://pubmed.ncbi.nlm.nih.gov/15986429/
5. Wang, Jiajia, Ma, Xin, Ma, Jie. 2021. Identification of Four Enhancer-Associated Genes as Risk Signature for Diffuse Glioma Patients. In Journal of molecular neuroscience : MN, 72, 410-419. doi:10.1007/s12031-021-01861-3. https://pubmed.ncbi.nlm.nih.gov/34462884/
智鼠故事 
